Ariad Pharmaceuticals Inc fka ARIA

[micanwait]

BR -- Just my guess. They are being cute about this pending the outcome of some funding development.. partnership, buyout etc.

If they are in discussions with a major pharma, I think their option on the space is actually an asset. Well-located Cambridge industrial/biotech property is very limited and very expensive.

Without such a development I doubt their projected Iclusig and pipeline income over the next several years could pay the rent. Prior to the FDA disaster they could have easily paid with some dilution, but I doubt that is much of an option at these levels. Of course, jmo.